SCHEMBL29936610

SCHEMBL29936610

CCN(CC)CCN(C)c1cc(OC)c(Nc2cc(Nc3ccccc3-n3cccn3)ncn2)cc1N

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.51
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
CDK4 P11802 1/20 0.34
CDK2 P24941 1/20 0.34
ALK Q9UM73 3/20 0.34
AURKA O14965 1/20 0.34
KIT P10721 1/20 0.34
FLT3 P36888 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
EML4 Q9HC35 2/20 0.33
IGF1R P08069 1/20 0.33
HCRTR1 O43613 1/20 0.33
HCRTR2 O43614 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
ERBB3 P21860 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24662651 1.00 EGFR (0.51) EGFRNPC1ALDH1A1RAB9ACDK4
SCHEMBL27004238 0.90 EGFR (0.44) EGFRNPC1ALDH1A1RAB9AALK
SCHEMBL29936795 0.86 EGFR (0.50) EGFRALDH1A1CDK4CDK2ALK
SCHEMBL24663094 0.86 EGFR (0.50) EGFRALDH1A1CDK4CDK2ALK
SCHEMBL24662609 0.84 EGFR (0.74) EGFRALKEML4ERBB3
SCHEMBL29936744 0.84 EGFR (0.74) EGFRALKEML4ERBB3
SCHEMBL24663098 0.76 EGFR (0.84) EGFRALKEML4ERBB3
SCHEMBL29936740 0.76 EGFR (0.84) EGFRALKEML4ERBB3
SCHEMBL27004241 0.74 EGFR (0.71) EGFRALKEML4IGF1RERBB3
SCHEMBL27004222 0.72 EGFR (0.60) EGFRALKEML4ERBB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022191664-A1 NOVEL PYRIMIDINE DERIVATIVE SHOWING INHIBITION EFFECT ON GROWTH OF CANCER CELLS 주식회사 온코빅스 2022-09-15 WO disclosed